Josh Enomoto

Josh Enomoto

As a financial analyst who has engaged in multimillion dollar projects with Global 500 companies, Joshua Enomoto provides an acute perspective of the investment markets.

A graduate of the University of California, San Diego, his professional experience covers multiple industries, including healthcare, civil engineering, and consumer electronics. Past contributions include leading the resolution of a critical liabilities dispute between two major electronics companies, and being awarded a speaking engagement in Tokyo, Japan, regarding supply chain efficiency protocols.

Currently based in San Diego, Josh is also an avid music composer and audio engineer, and spends his free time with multimedia pursuits.

Recent Articles

It’s Been Tough, but DIS Stock Will Regain the Magic Eventually

In the long run, DIS stock has a very compelling bullish narrative. But you must also recognize the signs of the times, which are not at all positive.

9 Stocks to Buy to Profit off the Baby Boomer Generation

Baby boomers have a reputation of being old and therefore irrelevant. However, this powerful and influential generation can spark huge demand for many stocks to buy.

It’s Tough to Admit, but Our New Normal Might Justify Buying IBIO Stock

IBIO stock seems like a speculative trade and it’s exactly that. However, the terrible costs associated with fighting the coronavirus makes iBio extremely relevant.

I Put MGM Stock on a ‘Deathwatch’ for a Reason … and Little has Changed

It’s difficult to see any upside for MGM stock for some time. After the coronavirus fades, the economic stability of the U.S. remains a huge question mark.

Blue Apron Stock Will Eventually See Red

One of the surprising performances of this year has been recorded by Blue Apron stock. However, I wouldn’t expect it to last much longer given that its coronavirus catalyst will eventually fade.